A 10-Year Experience with 290 Pancreas Transplants at a Single Institution
- 1 September 1989
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 210 (3) , 274-288
- https://doi.org/10.1097/00000658-198909000-00003
Abstract
Since our report at the 1984 American Surgical Association meeting of 100 pancreas transplants from 1966 through 1983, another 190 have been performed. The current series, begun in 1978, now numbers 276 cases, and includes 133 nonuremic recipients of pancreas transplants alone (PTA), 46 simultaneous pancreas/kidney transplants (SPK), and 97 pancreas tranplants after a kidney transplant (PAK). Duct management techniques used were free intraperitoneal drainage in 44 cases, duct occlusion in 44, enteric drainage in 89, and bladder drainage in 128. The 1-year patient and graft survival rates in the entire cohort of 276 were 91% and 42%. One-year patient survival rates were 88% in the first 100, 91% in the second 100, and 92% in the last 76 cases; corresponding 1-year graft survival rates were 28%, 47%, and 56% (p less than 0.05). A prospective comparison of bladder drainage (n = 82) versus enteric drainage (n = 46) in PAK/PTA cases since November 1, 1984 favored bladder drainage (1-year graft survival rates of 52% vs. 41%) because of urinary amylase monitoring. The best results were in recipients of primary SPK bladder-drained transplants (n = 39), with a 1-year pancreas graft survival rate of 75%, kidney graft survival rate of 80%, and patient survival rate of 95%. Logistic regression analysis, with 1-year graft function as the independent variable, showed significant (p less than 0.05) predictors of success (odds ratio) to be technique: bladder drainage (5.8) versus enteric drainage (2.5) versus duct injection (1.0); category: SPK (6.0) versus PAK from same donor (3.2) versus PAK from different donor (1.2) versus PTA (1.0); and donor HLA DR mismatch: 0 (5.0) versus 1 (2.5) versus 2 (1.0) antigens. On April 1, 1989, 90 patients had functioning grafts (60 euglycemic and insulin-free for more than 1 year, 10 for 5 to 10 years); these, along with 24 others whose grafts functioned for 1 to 6 years before failing, are part of an expanding cohort in whom the influence of inducing a euglycemic state on pre-existing secondary complications of diabetes is being studied. Only preliminary data is available. In regard to neuropathy, at more than 1 year after transplant in patients with functioning grafts, conduction velocities in some nerves were increased over baseline. In regard to retinopathy, deterioration in grade occurred in approximately 30% of the recipients by 3 years, whether the graft functioned continuously or failed early, but thereafter retinopathy in the patients with functioning grafts remained stable.(ABSTRACT TRUNCATED AT 400 WORDS)Keywords
This publication has 55 references indexed in Scilit:
- Specific immunological tolerance/optimal graft function in the absence of immunosuppressive therapy.1989
- Metabolic Effect of Hemipancreatectomy in Donors: Preoperative Prediction of Postoperative Oral Glucose ToleranceDiabetes, 1989
- Is HLA matching relevant in pancreas transplantation?Transplant International, 1988
- Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression.1987
- Pancreas transplant results according to the technique of duct management: bladder versus enteric drainage.1987
- FUNCTION OF TRANSPLANTED HUMAN PANCREATIC ALLOGRAFTS AFTER PRESERVATION IN COLD STORAGE FOE 6 to 26 HOURSTransplantation, 1987
- Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation.1987
- SURGICAL-TREATMENT OF DIABETIC NEPHROPATHY WITH SIMULTANEOUS PANCREATIC DUODENAL AND RENAL-TRANSPLANTATION1986
- Intraperitoneal transplantation of immediately vascularized segmental pancreatic grafts without duct ligation. A clinical trial.1979
- Transplantation of the pancreas.1976